Global Kidney Cancer Diagnostics Market Growth 2020-2025
According to this study, over the next five years the Kidney Cancer Diagnostics market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Kidney Cancer Diagnostics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Kidney Cancer Diagnostics market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Kidney Cancer Diagnostics, covering the supply chain analysis, impact assessment to the Kidney Cancer Diagnostics market size growth rate in several scenarios, and the measures to be undertaken by Kidney Cancer Diagnostics companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Immunohistochemistry
Urine Analysis
Blood Chemistry Test
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Specialty Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Thermo Fisher Scientific
Rosetta Genomics
Abbott Laboratories
Quest Diagnostics Incorporated
Roche Holding
Illumina
NanoString Technologies
Myriad Genetics
Sysmex Corporation
NeoGenomics Laboratories
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Kidney Cancer Diagnostics consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Kidney Cancer Diagnostics market by identifying its various subsegments.
Focuses on the key global Kidney Cancer Diagnostics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Kidney Cancer Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Kidney Cancer Diagnostics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Kidney Cancer Diagnostics Consumption 2015-2025
2.1.2 Kidney Cancer Diagnostics Consumption CAGR by Region
2.2 Kidney Cancer Diagnostics Segment by Type
2.2.1 Immunohistochemistry
2.2.2 Urine Analysis
2.2.3 Blood Chemistry Test
2.2.4 Others
2.3 Kidney Cancer Diagnostics Consumption by Type
2.3.1 Global Kidney Cancer Diagnostics Consumption Market Share by Type (2015-2020)
2.3.2 Global Kidney Cancer Diagnostics Revenue and Market Share by Type (2015-2020)
2.3.3 Global Kidney Cancer Diagnostics Sale Price by Type (2015-2020)
2.4 Kidney Cancer Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Others
2.5 Kidney Cancer Diagnostics Consumption by Application
2.5.1 Global Kidney Cancer Diagnostics Consumption Market Share by Type (2015-2020)
2.5.2 Global Kidney Cancer Diagnostics Value and Market Share by Type (2015-2020)
2.5.3 Global Kidney Cancer Diagnostics Sale Price by Type (2015-2020)
3 Global Kidney Cancer Diagnostics by Company
3.1 Global Kidney Cancer Diagnostics Sales Market Share by Company
3.1.1 Global Kidney Cancer Diagnostics Sales by Company (2018-2020)
3.1.2 Global Kidney Cancer Diagnostics Sales Market Share by Company (2018-2020)
3.2 Global Kidney Cancer Diagnostics Revenue Market Share by Company
3.2.1 Global Kidney Cancer Diagnostics Revenue by Company (2018-2020)
3.2.2 Global Kidney Cancer Diagnostics Revenue Market Share by Company (2018-2020)
3.3 Global Kidney Cancer Diagnostics Sale Price by Company
3.4 Global Kidney Cancer Diagnostics Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Kidney Cancer Diagnostics Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Kidney Cancer Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Kidney Cancer Diagnostics by Regions
4.1 Kidney Cancer Diagnostics by Regions
4.2 Americas Kidney Cancer Diagnostics Consumption Growth
4.3 APAC Kidney Cancer Diagnostics Consumption Growth
4.4 Europe Kidney Cancer Diagnostics Consumption Growth
4.5 Middle East & Africa Kidney Cancer Diagnostics Consumption Growth
5 Americas
5.1 Americas Kidney Cancer Diagnostics Consumption by Countries
5.1.1 Americas Kidney Cancer Diagnostics Consumption by Countries (2015-2020)
5.1.2 Americas Kidney Cancer Diagnostics Value by Countries (2015-2020)
5.2 Americas Kidney Cancer Diagnostics Consumption by Type
5.3 Americas Kidney Cancer Diagnostics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Kidney Cancer Diagnostics Consumption by Regions
6.1.1 APAC Kidney Cancer Diagnostics Consumption by Regions (2015-2020)
6.1.2 APAC Kidney Cancer Diagnostics Value by Regions (2015-2020)
6.2 APAC Kidney Cancer Diagnostics Consumption by Type
6.3 APAC Kidney Cancer Diagnostics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Kidney Cancer Diagnostics by Countries
7.1.1 Europe Kidney Cancer Diagnostics Consumption by Countries (2015-2020)
7.1.2 Europe Kidney Cancer Diagnostics Value by Countries (2015-2020)
7.2 Europe Kidney Cancer Diagnostics Consumption by Type
7.3 Europe Kidney Cancer Diagnostics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Kidney Cancer Diagnostics by Countries
8.1.1 Middle East & Africa Kidney Cancer Diagnostics Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Kidney Cancer Diagnostics Value by Countries (2015-2020)
8.2 Middle East & Africa Kidney Cancer Diagnostics Consumption by Type
8.3 Middle East & Africa Kidney Cancer Diagnostics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Kidney Cancer Diagnostics Distributors
10.3 Kidney Cancer Diagnostics Customer
11 Global Kidney Cancer Diagnostics Market Forecast
11.1 Global Kidney Cancer Diagnostics Consumption Forecast (2021-2025)
11.2 Global Kidney Cancer Diagnostics Forecast by Regions
11.2.1 Global Kidney Cancer Diagnostics Forecast by Regions (2021-2025)
11.2.2 Global Kidney Cancer Diagnostics Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Kidney Cancer Diagnostics Forecast by Type
11.8 Global Kidney Cancer Diagnostics Forecast by Application
12 Key Players Analysis
12.1 Thermo Fisher Scientific
12.1.1 Company Information
12.1.2 Kidney Cancer Diagnostics Product Offered
12.1.3 Thermo Fisher Scientific Kidney Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Thermo Fisher Scientific Latest Developments
12.2 Rosetta Genomics
12.2.1 Company Information
12.2.2 Kidney Cancer Diagnostics Product Offered
12.2.3 Rosetta Genomics Kidney Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Rosetta Genomics Latest Developments
12.3 Abbott Laboratories
12.3.1 Company Information
12.3.2 Kidney Cancer Diagnostics Product Offered
12.3.3 Abbott Laboratories Kidney Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Abbott Laboratories Latest Developments
12.4 Quest Diagnostics Incorporated
12.4.1 Company Information
12.4.2 Kidney Cancer Diagnostics Product Offered
12.4.3 Quest Diagnostics Incorporated Kidney Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Quest Diagnostics Incorporated Latest Developments
12.5 Roche Holding
12.5.1 Company Information
12.5.2 Kidney Cancer Diagnostics Product Offered
12.5.3 Roche Holding Kidney Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Roche Holding Latest Developments
12.6 Illumina
12.6.1 Company Information
12.6.2 Kidney Cancer Diagnostics Product Offered
12.6.3 Illumina Kidney Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Illumina Latest Developments
12.7 NanoString Technologies
12.7.1 Company Information
12.7.2 Kidney Cancer Diagnostics Product Offered
12.7.3 NanoString Technologies Kidney Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 NanoString Technologies Latest Developments
12.8 Myriad Genetics
12.8.1 Company Information
12.8.2 Kidney Cancer Diagnostics Product Offered
12.8.3 Myriad Genetics Kidney Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Myriad Genetics Latest Developments
12.9 Sysmex Corporation
12.9.1 Company Information
12.9.2 Kidney Cancer Diagnostics Product Offered
12.9.3 Sysmex Corporation Kidney Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Sysmex Corporation Latest Developments
12.10 NeoGenomics Laboratories
12.10.1 Company Information
12.10.2 Kidney Cancer Diagnostics Product Offered
12.10.3 NeoGenomics Laboratories Kidney Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 NeoGenomics Laboratories Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Kidney Cancer Diagnostics Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Immunohistochemistry
Table 5. Major Players of Urine Analysis
Table 6. Major Players of Blood Chemistry Test
Table 7. Major Players of Others
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Kidney Cancer Diagnostics Consumption Market Share by Type (2015-2020)
Table 10. Global Kidney Cancer Diagnostics Revenue by Type (2015-2020) ($ million)
Table 11. Global Kidney Cancer Diagnostics Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Kidney Cancer Diagnostics Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Kidney Cancer Diagnostics Consumption Market Share by Application (2015-2020)
Table 15. Global Kidney Cancer Diagnostics Value by Application (2015-2020)
Table 16. Global Kidney Cancer Diagnostics Value Market Share by Application (2015-2020)
Table 17. Global Kidney Cancer Diagnostics Sale Price by Application (2015-2020)
Table 18. Global Kidney Cancer Diagnostics Sales by Company (2017-2019) (K Units)
Table 19. Global Kidney Cancer Diagnostics Sales Market Share by Company (2017-2019)
Table 20. Global Kidney Cancer Diagnostics Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Kidney Cancer Diagnostics Revenue Market Share by Company (2017-2019)
Table 22. Global Kidney Cancer Diagnostics Sale Price by Company (2017-2019)
Table 23. Global Kidney Cancer Diagnostics Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Kidney Cancer Diagnostics Products Offered
Table 25. Kidney Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Kidney Cancer Diagnostics Consumption by Regions 2015-2020 (K Units)
Table 27. Global Kidney Cancer Diagnostics Consumption Market Share by Regions 2015-2020
Table 28. Global Kidney Cancer Diagnostics Value by Regions 2015-2020 ($ Millions)
Table 29. Global Kidney Cancer Diagnostics Value Market Share by Regions 2015-2020
Table 30. Americas Kidney Cancer Diagnostics Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Kidney Cancer Diagnostics Consumption Market Share by Countries (2015-2020)
Table 32. Americas Kidney Cancer Diagnostics Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Kidney Cancer Diagnostics Value Market Share by Countries (2015-2020)
Table 34. Americas Kidney Cancer Diagnostics Consumption by Type (2015-2020) (K Units)
Table 35. Americas Kidney Cancer Diagnostics Consumption Market Share by Type (2015-2020)
Table 36. Americas Kidney Cancer Diagnostics Consumption by Application (2015-2020) (K Units)
Table 37. Americas Kidney Cancer Diagnostics Consumption Market Share by Application (2015-2020)
Table 38. APAC Kidney Cancer Diagnostics Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Kidney Cancer Diagnostics Consumption Market Share by Countries (2015-2020)
Table 40. APAC Kidney Cancer Diagnostics Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Kidney Cancer Diagnostics Value Market Share by Regions (2015-2020)
Table 42. APAC Kidney Cancer Diagnostics Consumption by Type (2015-2020) (K Units)
Table 43. APAC Kidney Cancer Diagnostics Consumption Market Share by Type (2015-2020)
Table 44. APAC Kidney Cancer Diagnostics Consumption by Application (2015-2020) (K Units)
Table 45. APAC Kidney Cancer Diagnostics Consumption Market Share by Application (2015-2020)
Table 46. Europe Kidney Cancer Diagnostics Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Kidney Cancer Diagnostics Consumption Market Share by Countries (2015-2020)
Table 48. Europe Kidney Cancer Diagnostics Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Kidney Cancer Diagnostics Value Market Share by Countries (2015-2020)
Table 50. Europe Kidney Cancer Diagnostics Consumption by Type (2015-2020) (K Units)
Table 51. Europe Kidney Cancer Diagnostics Consumption Market Share by Type (2015-2020)
Table 52. Europe Kidney Cancer Diagnostics Consumption by Application (2015-2020) (K Units)
Table 53. Europe Kidney Cancer Diagnostics Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Kidney Cancer Diagnostics Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Kidney Cancer Diagnostics Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Kidney Cancer Diagnostics Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Kidney Cancer Diagnostics Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Kidney Cancer Diagnostics Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Kidney Cancer Diagnostics Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Kidney Cancer Diagnostics Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Kidney Cancer Diagnostics Consumption Market Share by Application (2015-2020)
Table 62. Kidney Cancer Diagnostics Distributors List
Table 63. Kidney Cancer Diagnostics Customer List
Table 64. Global Kidney Cancer Diagnostics Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Kidney Cancer Diagnostics Consumption Market Forecast by Regions
Table 66. Global Kidney Cancer Diagnostics Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Kidney Cancer Diagnostics Value Market Share Forecast by Regions
Table 68. Global Kidney Cancer Diagnostics Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Kidney Cancer Diagnostics Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Kidney Cancer Diagnostics Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Kidney Cancer Diagnostics Value Market Share Forecast by Type (2021-2025)
Table 72. Global Kidney Cancer Diagnostics Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Kidney Cancer Diagnostics Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Kidney Cancer Diagnostics Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Kidney Cancer Diagnostics Value Market Share Forecast by Application (2021-2025)
Table 76. Thermo Fisher Scientific Product Offered
Table 77. Thermo Fisher Scientific Kidney Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. Thermo Fisher Scientific Main Business
Table 79. Thermo Fisher Scientific Latest Developments
Table 80. Thermo Fisher Scientific Basic Information, Company Total Revenue (in $ million), Kidney Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 81. Rosetta Genomics Product Offered
Table 82. Rosetta Genomics Kidney Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. Rosetta Genomics Main Business
Table 84. Rosetta Genomics Latest Developments
Table 85. Rosetta Genomics Basic Information, Company Total Revenue (in $ million), Kidney Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 86. Abbott Laboratories Product Offered
Table 87. Abbott Laboratories Kidney Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. Abbott Laboratories Main Business
Table 89. Abbott Laboratories Latest Developments
Table 90. Abbott Laboratories Basic Information, Company Total Revenue (in $ million), Kidney Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 91. Quest Diagnostics Incorporated Product Offered
Table 92. Quest Diagnostics Incorporated Kidney Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Quest Diagnostics Incorporated Main Business
Table 94. Quest Diagnostics Incorporated Latest Developments
Table 95. Quest Diagnostics Incorporated Basic Information, Company Total Revenue (in $ million), Kidney Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 96. Roche Holding Product Offered
Table 97. Roche Holding Kidney Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Roche Holding Main Business
Table 99. Roche Holding Latest Developments
Table 100. Roche Holding Basic Information, Company Total Revenue (in $ million), Kidney Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 101. Illumina Product Offered
Table 102. Illumina Kidney Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. Illumina Main Business
Table 104. Illumina Latest Developments
Table 105. Illumina Basic Information, Company Total Revenue (in $ million), Kidney Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 106. NanoString Technologies Product Offered
Table 107. NanoString Technologies Basic Information, Company Total Revenue (in $ million), Kidney Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 108. NanoString Technologies Main Business
Table 109. NanoString Technologies Latest Developments
Table 110. NanoString Technologies Kidney Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Myriad Genetics Product Offered
Table 112. Myriad Genetics Kidney Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Myriad Genetics Main Business
Table 114. Myriad Genetics Latest Developments
Table 115. Myriad Genetics Basic Information, Company Total Revenue (in $ million), Kidney Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 116. Sysmex Corporation Product Offered
Table 117. Sysmex Corporation Kidney Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 118. Sysmex Corporation Main Business
Table 119. Sysmex Corporation Latest Developments
Table 120. Sysmex Corporation Basic Information, Company Total Revenue (in $ million), Kidney Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 121. NeoGenomics Laboratories Product Offered
Table 122. NeoGenomics Laboratories Kidney Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 123. NeoGenomics Laboratories Main Business
Table 124. NeoGenomics Laboratories Latest Developments
Table 125. NeoGenomics Laboratories Basic Information, Company Total Revenue (in $ million), Kidney Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Kidney Cancer Diagnostics
Figure 2. Kidney Cancer Diagnostics Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Kidney Cancer Diagnostics Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Kidney Cancer Diagnostics Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Immunohistochemistry
Figure 7. Product Picture of Urine Analysis
Figure 8. Product Picture of Blood Chemistry Test
Figure 9. Product Picture of Others
Figure 10. Global Kidney Cancer Diagnostics Consumption Market Share by Type (2015-2020)
Figure 11. Global Kidney Cancer Diagnostics Value Market Share by Type (2015-2020)
Figure 12. Kidney Cancer Diagnostics Consumed in Hospitals
Figure 13. Global Kidney Cancer Diagnostics Market: Hospitals (2015-2020) (K Units)
Figure 14. Global Kidney Cancer Diagnostics Market: Hospitals (2015-2020) ($ Millions)
Figure 15. Kidney Cancer Diagnostics Consumed in Specialty Clinics
Figure 16. Global Kidney Cancer Diagnostics Market: Specialty Clinics (2015-2020) (K Units)
Figure 17. Global Kidney Cancer Diagnostics Market: Specialty Clinics (2015-2020) ($ Millions)
Figure 18. Kidney Cancer Diagnostics Consumed in Others
Figure 19. Global Kidney Cancer Diagnostics Market: Others (2015-2020) (K Units)
Figure 20. Global Kidney Cancer Diagnostics Market: Others (2015-2020) ($ Millions)
Figure 21. Global Kidney Cancer Diagnostics Consumption Market Share by Application (2015-2020)
Figure 22. Global Kidney Cancer Diagnostics Value Market Share by Application (2015-2020)
Figure 23. Global Kidney Cancer Diagnostics Sales Market Share by Company in 2017
Figure 24. Global Kidney Cancer Diagnostics Sales Market Share by Company in 2019
Figure 25. Global Kidney Cancer Diagnostics Revenue Market Share by Company in 2017
Figure 26. Global Kidney Cancer Diagnostics Revenue Market Share by Company in 2019
Figure 27. Global Kidney Cancer Diagnostics Sale Price by Company in 2019
Figure 28. Global Kidney Cancer Diagnostics Consumption Market Share by Regions 2015-2020
Figure 29. Global Kidney Cancer Diagnostics Value Market Share by Regions 2015-2020
Figure 30. Americas Kidney Cancer Diagnostics Consumption 2015-2020 (K Units)
Figure 31. Americas Kidney Cancer Diagnostics Value 2015-2020 ($ Millions)
Figure 32. APAC Kidney Cancer Diagnostics Consumption 2015-2020 (K Units)
Figure 33. APAC Kidney Cancer Diagnostics Value 2015-2020 ($ Millions)
Figure 34. Europe Kidney Cancer Diagnostics Consumption 2015-2020 (K Units)
Figure 35. Europe Kidney Cancer Diagnostics Value 2015-2020 ($ Millions)
Figure 36. Middle East & Africa Kidney Cancer Diagnostics Consumption 2015-2020 (K Units)
Figure 37. Middle East & Africa Kidney Cancer Diagnostics Value 2015-2020 ($ Millions)
Figure 38. Americas Kidney Cancer Diagnostics Consumption Market Share by Countries in 2019
Figure 39. Americas Kidney Cancer Diagnostics Value Market Share by Countries in 2019
Figure 40. Americas Kidney Cancer Diagnostics Consumption Market Share by Type in 2019
Figure 41. Americas Kidney Cancer Diagnostics Consumption Market Share by Application in 2019
Figure 42. United States Kidney Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 43. United States Kidney Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 44. Canada Kidney Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 45. Canada Kidney Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 46. Mexico Kidney Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 47. Mexico Kidney Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 48. APAC Kidney Cancer Diagnostics Consumption Market Share by Countries in 2019
Figure 49. APAC Kidney Cancer Diagnostics Value Market Share by Regions in 2019
Figure 50. APAC Kidney Cancer Diagnostics Consumption Market Share by Type in 2019
Figure 51. APAC Kidney Cancer Diagnostics Consumption Market Share by Application in 2019
Figure 52. China Kidney Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 53. China Kidney Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 54. Japan Kidney Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 55. Japan Kidney Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 56. Korea Kidney Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 57. Korea Kidney Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 58. Southeast Asia Kidney Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 59. Southeast Asia Kidney Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 60. India Kidney Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 61. India Kidney Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 62. Australia Kidney Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 63. Australia Kidney Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 64. Europe Kidney Cancer Diagnostics Consumption Market Share by Countries in 2019
Figure 65. Europe Kidney Cancer Diagnostics Value Market Share by Countries in 2019
Figure 66. Europe Kidney Cancer Diagnostics Consumption Market Share by Type in 2019
Figure 67. Europe Kidney Cancer Diagnostics Consumption Market Share by Application in 2019
Figure 68. Germany Kidney Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 69. Germany Kidney Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 70. France Kidney Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 71. France Kidney Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 72. UK Kidney Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 73. UK Kidney Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 74. Italy Kidney Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 75. Italy Kidney Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 76. Russia Kidney Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 77. Russia Kidney Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 78. Middle East & Africa Kidney Cancer Diagnostics Consumption Market Share by Countries in 2019
Figure 79. Middle East & Africa Kidney Cancer Diagnostics Value Market Share by Countries in 2019
Figure 80. Middle East & Africa Kidney Cancer Diagnostics Consumption Market Share by Type in 2019
Figure 81. Middle East & Africa Kidney Cancer Diagnostics Consumption Market Share by Application in 2019
Figure 82. Egypt Kidney Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 83. Egypt Kidney Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 84. South Africa Kidney Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 85. South Africa Kidney Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 86. Israel Kidney Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 87. Israel Kidney Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 88. Turkey Kidney Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 89. Turkey Kidney Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 90. GCC Countries Kidney Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 91. GCC Countries Kidney Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 92. Global Kidney Cancer Diagnostics Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 93. Global Kidney Cancer Diagnostics Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 94. Americas Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 95. Americas Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 96. APAC Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 97. APAC Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 98. Europe Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 99. Europe Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 100. Middle East & Africa Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 101. Middle East & Africa Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 102. United States Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 103. United States Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 104. Canada Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 105. Canada Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 106. Mexico Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 107. Mexico Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 108. Brazil Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 109. Brazil Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 110. China Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 111. China Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 112. Japan Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 113. Japan Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 114. Korea Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 115. Korea Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 116. Southeast Asia Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 117. Southeast Asia Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 118. India Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 119. India Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 120. Australia Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 121. Australia Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 122. Germany Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 123. Germany Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 124. France Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 125. France Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 126. UK Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 127. UK Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 128. Italy Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 129. Italy Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 130. Russia Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 131. Russia Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 132. Spain Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 133. Spain Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 134. Egypt Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 135. Egypt Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 136. South Africa Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 137. South Africa Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 138. Israel Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 139. Israel Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 140. Turkey Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 141. Turkey Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 142. GCC Countries Kidney Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 143. GCC Countries Kidney Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 144. Thermo Fisher Scientific Kidney Cancer Diagnostics Market Share (2018-2020)
Figure 145. Rosetta Genomics Kidney Cancer Diagnostics Market Share (2018-2020)
Figure 146. Abbott Laboratories Kidney Cancer Diagnostics Market Share (2018-2020)
Figure 147. Quest Diagnostics Incorporated Kidney Cancer Diagnostics Market Share (2018-2020)
Figure 148. Roche Holding Kidney Cancer Diagnostics Market Share (2018-2020)
Figure 149. Illumina Kidney Cancer Diagnostics Market Share (2018-2020)
Figure 150. NanoString Technologies Kidney Cancer Diagnostics Market Share (2018-2020)
Figure 151. Myriad Genetics Kidney Cancer Diagnostics Market Share (2018-2020)
Figure 152. Sysmex Corporation Kidney Cancer Diagnostics Market Share (2018-2020)
Figure 153. NeoGenomics Laboratories Kidney Cancer Diagnostics Market Share (2018-2020)
